IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 224 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $106,445 | -62.5% | 16,658 | -48.1% | 0.02% | -30.4% |
| Q4 2018 | $284,000 | -21.3% | 32,093 | 0.0% | 0.02% | -14.8% |
| Q3 2018 | $361,000 | -12.2% | 32,093 | 0.0% | 0.03% | -20.6% |
| Q2 2018 | $411,000 | -24.2% | 32,093 | 0.0% | 0.03% | -12.8% |
| Q1 2018 | $542,000 | +110.9% | 32,093 | 0.0% | 0.04% | +69.6% |
| Q4 2017 | $257,000 | +3.2% | 32,093 | 0.0% | 0.02% | -8.0% |
| Q3 2017 | $249,000 | +5.5% | 32,093 | 0.0% | 0.02% | -7.4% |
| Q2 2017 | $236,000 | – | 32,093 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 12,201,261 | $203,150,000 | 4.07% |
| Paradigm Biocapital Advisors LP | 907,428 | $15,109,000 | 4.00% |
| Avoro Capital Advisors LLC | 9,125,000 | $151,931,000 | 2.77% |
| Logos Global Management LP | 1,000,000 | $16,650,000 | 2.16% |
| Avidity Partners Management LP | 6,043,219 | $100,620,000 | 2.10% |
| Orbimed Advisors | 6,633,006 | $110,440,000 | 1.79% |
| Parametrica Management Ltd | 134,679 | $2,240,000 | 1.66% |
| Boxer Capital, LLC | 1,935,133 | $32,220,000 | 1.66% |
| Fairmount Funds Management LLC | 389,588 | $6,487,000 | 1.53% |
| Long Focus Capital Management, LLC | 705,000 | $11,738,000 | 1.51% |